# Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients

> **NCT00586794** · PHASE3 · TERMINATED · sponsor: **Competence Network for Congenital Heart Defects** · enrollment: 24 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension (PAH)

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00586794
- **Lead sponsor:** Competence Network for Congenital Heart Defects
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586794, "Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00586794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*